Document is current
Any future updates will be listed below
-
Authors
Aletaha, Daniel
Smolen, Josef S. https://orcid.org/0000-0002-4302-8877
- License Information
-
More Information
Article History
First Online: 19 August 2019
Competing interests
: D. Aletaha declares that he has received personal fees from AbbVie, Eli Lilly, Janssen, Medac, Merck Sharp & Dohme, Pfizer, Roche, Sanofi/Genzyme and UCB, and grants from AbbVie, Bristol-Myers Squibb, and Merck Sharp & Dohme. J.S. Smolen declares that he has received grants for his institution from AbbVie, AstraZeneca, Janssen, Eli Lilly, Merck Sharp & Dohme, Novartis, Pfizer and Roche, and that he has provided expert advice or had symposia speaking engagements for AbbVie, Amgen, AstraZeneca, Astro, Bristol-Myers Squibb, Celgene, Celltrion, Chugai, Gilead, ILTOO, Janssen, Eli Lilly, Merck Sharp & Dohme, Novartis-Sandoz, Pfizer, Roche, Samsung, Sanofi and UCB.
